We developed an individual-based microsimulation model of adults (ages 18 and over) in a community in rural KwaZulu-Natal (KZN). The aim of the analysis was to evaluate the health impact and costeffectiveness of community-based HIV testing and counseling (HTC) with enhanced linkage to care through home visits (home HTC) compared to a 'status quo' scenario with ongoing current levels of facility-based HIV testing and ART uptake (SQ; Box 1). The analysis was repeated with expanding ART eligibility criteria of ≤200, ≤350 and ≤500 CD4 cells/mm 3 . The model is run with a one-month time step Both scenarios repeated for ART eligibility at ≤200, ≤350, ≤500 and all HIV-positive.
Population and behaviour
The home HTC pilot study enumerated all individuals in a community of 285 households but only adults aged 18 and over who resided in the household for at least two nights per week were eligible for the intervention. The model simulates all adults in the community irrespective of eligibility (mean community size = 769 adults). Individuals are grouped into households (n=285) with cohabiting and noncohabiting couples explicitly defined. Household size is randomly allocated according to the distribution observed in the pilot study ( Figure S1 ). The model replicates the gender and age distribution of the community recorded in the pilot survey (Table S1 ) stratified according to position in the household: household head, cohabiting partner of household head or other members of the household. First, each household is assigned a household head, 37% of whom are assumed to be male.
1 Each household head is randomly assigned an age category from the observed distribution and their specific age is generated from a uniform distribution across the whole category. Table S2 . Age difference between household heads and their cohabiting partners or other household members. The main partner of the household head was a cohabitant in 26.3% of all households; these are all assumed to be female partners of male household heads. The remaining individuals in each household are modeled as other household members, 33.2% of whom are male. The ages of cohabiting partners and other household members are randomly assigned from a discrete distribution relative to the age of the household head (Table S2) .
Age difference (years)
Household
Study eligibility
In the pilot study, n=90 out of 769 individuals (21% of men and 8% of women) enumerated in the household survey were ineligible or did not consent to the intervention. These are disproportionately
represented by men and heads of households, and in the model we assume that 80% of the nonintervention men are household heads who are doing migrant work. Migrant workers are considered to be present in the community for one month in every twelve where they form partnerships and contribute to transmission within the community. For the remainder of the time they do not engage in any sex acts with any long-term partner within the study community, but both they and any long-term partner are subject to an elevated risk of short-term partnership formation. Short-term partners who are external to the community are not explicitly modeled but are assumed to share the same age-and gender-specific HIV prevalence as that observed within the community in the baseline survey (Table S3) . 
Partnerships, coital frequency and condom use
The model simulates heterosexual transmission only, and sexual partnerships can be formed between any two adults of the opposite sex with a preference for the male partner to be slightly older than the female (modal age difference = 0-4 years in study data, unpublished).
Stable, or long-term, partnerships have a mean duration of 7.15 years in the data and we assume these can only be formed within the modelled community (either within the same household or with an adult in a different household). New long-term partnerships are formed dynamically by matching the number of stable partnerships within the community to the data ( Figure S2 ). Short-term partnerships have a mean duration of three months and are preferentially formed with other adults within the community.
Short-term partnership formation is demand-driven by either men or women (usually men who report higher numbers of partners, Table S4 ). If no adults are available within the community, short-term partners outside the community may be sought. These external adults are not explicitly modelled but have a probability of HIV infection based on the age and gender distribution of HIV prevalence within the study community (Table S3) .
Individuals may have a maximum of two concurrent partners at any time, only one of which may be long-term. The monthly probability of an existing partnership dissolving is calculated from the mean partnership duration using a negative exponential distribution. We assume that there is a minimum twomonth lag period between cessation of a partnership and formation of the next of the same type. Figure S2 ). These distributions are used for all women except those who are in a within-household relationship, who unanimously report one long-term partner only. (Table S5 ). All individuals are evaluated in a random order that is re-randomised every time-step, and the coital frequency used that month is the number assigned to whichever partner is evaluated first. We assume all short-term partnerships involve three sex acts per month, also based on the Partners HSV/HIV data and following the assumption made by Hallett et al. (Table S6 ) and individuals are reassigned when they test HIV-positive, form or dissolve a long-term partnership. In the study data, condom use at last sex was also significantly associated with age (p<0.001) but we do not capture this in the model. Condom use was not associated with gender (p=0.31).
Population turnover
Children and teenagers enumerated in the pilot survey enter the model as they reach age 18 years at a mean rate of 0.0025 per adult per month using Poisson random generation. Background (non-HIV) mortality rates for men and women are the result of fitting an exponential function ( ) to the estimates in an original analysis on South African survival data by Dorrington et al.
(http://www.mrc.ac.za/bod/1999report.pdf), as performed by Hallett et al. 2, 3 Parameters are (α=0.0015, β=0.062) for men and (α =0.0004, β =0.080) for women (where y is the mortality rate and x is the exact age). Survival probabilities for each member of any partnership are modeled independently.
HIV infection & transmission

Biological parameters
The baseline transmission probability per sex act, , is set at 0.1% 4 , and different HIV-related cofactors are applied according to each individual's attributes and behavior. Condom use and male circumcision reduce HIV transmission by 78% and 65% per sex act, respectively. 4, 5 Coinfections representing HSV2
and other STIs are assumed to increase HIV acquisition by a factor of 3.4 for women and 2.8 for men 6 and transmission by a factor of two (HSV2 is associated with an 0.18 increase in log VL 7 which equates to approximately 50% increase in infectiousness using 4 ). STIs are initially distributed by age and gender according to the observed HSV2 prevalence in sub-Saharan Africa and all individuals are subject to an STI incidence rate, which is evaluated every six months (Table S7) . Table S7 . Age-specific STI prevalence and incidence.
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HIV natural history
On infection, individuals progress to one of four CD4 cell categories with the probabilities given in Table   S8 . The CD4 count then progresses through each subsequent category until death. The mean years spent in each CD4 cell count category were derived from Lodi et al 2011 10 and a pooled-analysis of 
Male circumcision
Fifteen per-cent of all men are assumed to be circumcised; male circumcision status was not significantly associated with age in the pilot study (p=0.88) so this was applied uniformly across all ages and is assumed to be constant through time.
Model fitting
Age-and gender-specific incidence in the model was manually fitted to the pattern of incidence observed in rural KwaZulu-Natal in an independent population survey (Table S9) . 14, 15 For each gender and age group, the baseline transmission probability per sex act was multiplied by a fitting cofactor, . This cofactor is intended to represent all age-and gender-related differences in incidence as well as accounting for any misreporting of behavioural factors in the study data. All individuals may progress through a background care cascade comprising facility-based HIV testing, linkage to care and ART initiation regardless of whether or not they have been exposed to the home HTC intervention ( Figure S3 ). Progression rates between these stages are given in the form of a monthly probability of progression from one state to another. These are based on the recorded coverage of HIV testing, pre-ART clinic visit and ART use at the pilot and phase II baseline surveys and are detailed in Tables S8 and S10-S12. 
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HIV testing
The background coverage of HIV testing is specific to sex, age and infection status and is derived from the phase II baseline data (Table S10 ). This is used in the 'status quo' scenario, as well as during nonintervention years and for individuals who have not received the intervention in the home HTC scenario.
The observed coverage of having ever tested for HIV at baseline is multiplied by the proportion of those tested whose test was in the preceding year (41.0% for uninfected individuals and 69.7% for individuals who are HIV-positive but not on ART, irrespective of sex or age group) to estimate the proportion of individuals who test in one year. The monthly probability of HIV testing is then estimated using equation (eq.) 1. This method assumes that background HIV testing rates do not change over time and that all infected individuals will eventually get tested, unless they die first.
, , * , , * 1 (eq. 1) 
Linkage to care: pre-ART clinic visit
The baseline coverage for linkage to care, which we define as a pre-ART clinic visit, is specific to CD4 category status only and is derived from the pilot baseline data. We estimate a monthly probability from the observed proportions of individuals who have linked to care (all of whom have had an HIV test; eq.
2, Table S11 ). This method assumes that the rate of attending the clinic does not vary over time and that these individuals have attended the clinic in the past year. All infected individuals who have had an HIV test will eventually visit the clinic, unless they die first. We assume no change in the probability of linkage to care with expanding ART eligibility criteria. 
ART initiation
We assume that all individuals on ART at the time of the pilot baseline survey initiated therapy with a CD4 count of ≤200 cells/mm 3 . Therefore background ART initiation in the baseline scenario is only possible when an individual's CD4 count falls below this threshold. When the threshold is elevated to ≤350 cells/mm 3 , ≤500 cells/mm 3 and universal access for the alternative analyses, per-month ART initiation probabilities are assumed to halve for eligible individuals with CD4 351-500 cells/mm 3 and halve again for >500 cells/mm 3 . We also assume that individuals must visit the clinic before ART initiation can take place. All infected and eligible individuals who have had a clinic visit will eventually initiate ART, unless they die first.
After initiation, ART takes three months to reach full efficacy and infectiousness decays exponentially over this period to reach an overall reduction in infectivity of 96%. 16 Mortality on ART varies by the CD4 cell count at initiation and by the time since initiation (Table S12 ).
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Table S12. CD4-specific parameters for ART coverage and initiation.
Current CD4 category 
Intervention: community-based home HTC with facilitated referral
The home HTC intervention acts to strengthen the HIV care cascade via an immediate HIV test for all eligible and consenting adults together with increased linkage to care and ART uptake. It is implemented three times over the ten-year model run in the form of three rounds of simultaneous expanded HIV testing at 0, 4 and 8 years. All eligible and consenting adults receive an immediate HIV test unless they are already on ART, or have had an HIV test within the previous six months (we assume that the latter group are likely to withhold consent to the intervention). In the pilot study, HIV-positive individuals then received a point-of-care CD4 test and were referred to a local HIV clinic. In the model, all home HTCrelated changes last for one year post-intervention, after which testing and treatment-seeking behaviour returns to that observed in the SQ arm.
In the pilot study, n=90 out of 769 individuals (11.7%) were ineligible or did not consent to HIV testing, represented disproportionately by men and heads of households. We assumed that 80% of the nontested men are household heads who are doing migrant work to derive a joint distribution of intervention recipients that we use in the model (Table S13) . 
Linkage to care following home HTC
Following the home HTC intervention, 68% of HIV-positive individuals who were not previously linked to care had visited a clinic within a month, 89% within three months and 95% by the end of six months.
Clinic attendance following home HTC was not associated with CD4 count (p=0.087), age (p=0.84) or gender (p=0.80). To estimate the monthly probability of clinic attendance we fit an exponential distribution of the form 1 to this data using non-linear least squares (eq. 3).
0.932 1 .
(eq. 3)
Here, is per-month probability of an HIV-positive individual visiting clinic for the first time following the home HTC visit. This gives an estimated monthly probability of 67% linkage to care
following home HTC and we assume this does not vary in analyses with expanded ART initiation criteria.
ART initiation following home HTC
CD4 counts at ART initiation were not recorded in the pilot study and CD4 measurements taken during intervention follow-up visits measure reconstituted CD4 cell levels for individuals on ART. We assumed that 90% of individuals who started ART following home HTC had a CD4 count of ≤200 cells/mm 3 at initiation (other indicators for ART initiation include TB coinfection and pregnancy, which are not included in the model).
We fitted an exponential distribution to the proportion of HIV-positive individuals initiating ART to estimate the monthly probability of ART initiation post-home HTC (eq. 4). Time to ART initiation was calculated from the time of each individual's clinic visit assuming that this occurred at the mid-point between consecutive follow-up visits. (Table S14 ). We do not assume any changes in condom use or other sexual behavior relating to the intervention but condom use is associated with knowledge of HIV status (Table S6 ), therefore increased testing will lead to increased condom use in the population overall. Sensitivity analyses indicate that this does not significantly contribute to the overall intervention impact (data not shown).
Quantifying health states
Disability-adjusted life years (DALYs) are attached to each HIV-related health state and these are summed over all individuals for the duration of the model runtime. We use the same disability weights as described in Eaton, Menzies et al. (Table S15 ). Figure 2A compares the median HIV incidence over ten years in the model under the former ART eligibility criteria of ≤200 CD4 cell mm -3 to an independent survey from KwaZulu-Natal under the same national guidelines. 14 The predicted age-specific pattern in the model closely matches the observed data. Figure S4 . Model incidence Age-specific incidence over ten years with ART initiation at ≤200 CD4 cells mm A. Age and gender distribution at model initiation. B. Model incidence over ten years. C. CD4 category distribution over ten years with no intervention and ART eligibility at CD4 ≤200 cells/mm 3 .
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Model validation
D. CD4 category at ART initiation. E. Source of HIV transmissions over ten years by CD4 category with ART eligibility at CD4 ≤200 cells/mm 3 .
F. Source of HIV transmissions over ten years by partnership type with ART eligibility at CD4 ≤200 cells/mm 3 .
Sensitivity analyses DALY discount rate
DALYs are not discounted in the base-case scenario; we compare this to a 3% annual discount rate for all DALYs, implemented in the base case model. Table S17 shows that discounting DALYs at 3% per year increases the incremental cost per DALY averted by 18%-20% and increasing the cost discount rate from 3% to 6% decreases ICERs by 12-14%. 
